BiotechTube

LYR-210

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Chronic Sinusitis

Conditions

Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis)

Trial Timeline

May 9, 2019 → Feb 4, 2021

NCT ID
NCT04041609

About LYR-210

LYR-210 is a phase 2 stage product being developed by Lyra Therapeutics for Chronic Sinusitis. The current trial status is completed. This product is registered under clinical trial identifier NCT04041609. Target conditions include Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis).

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT04041609Phase 2Completed

Competing Products

20 competing products in Chronic Sinusitis

See all competitors
ProductCompanyStageHype Score
macitentan 10 mgBML, Inc.Phase 3
76
KPL-716 + PlaceboKiniksa PharmaceuticalsPhase 2
47
TERN-701Terns PharmaceuticalsPhase 1/2
38
Fludarabine + Cyclophosphamide + PRGN-3007PrecigenPhase 1
28
LY3556050 + PlaceboEli LillyPhase 2
52
THB001Third Harmonic BioPhase 1
25
BriquilimabJasper TherapeuticsPhase 1/2
33
BriquilimabJasper TherapeuticsPhase 1/2
33
BriquilimabJasper TherapeuticsPhase 2
44
Empagliflozin + Matching placeboEli LillyPhase 3
77
LY3461767 + PlaceboEli LillyPhase 1
33
Pirtobrutinib + Venetoclax + RituximabEli LillyPhase 3
77
LY3526318 + PlaceboEli LillyPhase 2
52
PirtobrutinibEli LillyPhase 2
52
Ibrutinib + LY3214996Eli LillyPhase 1
33
Pirtobrutinib + AcalabrutinibEli LillyPhase 2
52
LYR-220 Design 1 (Part 1 only) + LYR-220 Design 2 (Part 1 and Part 2) + Bilateral sham procedure control (Part 2)Lyra TherapeuticsPhase 2
44
480 Mometasone Furoate Sinus Drug DepotLyra TherapeuticsPhase 1
25
LYR-210 + Sham procedure controlLyra TherapeuticsPhase 3
69
LYR-210 + Sham procedure controlLyra TherapeuticsPhase 3
69

Other Products from Lyra Therapeutics

LYR-210 + Sham procedure controlPhase 3
69
LYR-210 + Sham procedure controlPhase 3
69
LYR-220 Design 1 (Part 1 only) + LYR-220 Design 2 (Part 1 and Part 2) + Bilateral sham procedure control (Part 2)Phase 2
44
480 Mometasone Furoate Sinus Drug DepotPhase 1
25